These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9288518)

  • 1. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model.
    Bannan S; Danby A; Cowan D; Ashraf S; Gesinde M; Martin P
    Eur J Cardiothorac Surg; 1997 Aug; 12(2):268-75. PubMed ID: 9288518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprotinin complements heparin bonding in an in vitro model of cardiopulmonary bypass.
    Bannan S; Martin PG
    Br J Haematol; 1998 Jun; 101(3):455-61. PubMed ID: 9633886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low heparinization with heparin-bonded bypass circuits: is it a safe strategy?
    Bannan S; Danby A; Cowan D; Ashraf S; Martin PG
    Ann Thorac Surg; 1997 Mar; 63(3):663-8. PubMed ID: 9066381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
    Aldea GS; Soltow LO; Chandler WL; Triggs CM; Vocelka CR; Crockett GI; Shin YT; Curtis WE; Verrier ED
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1.
    Kozek-Langenecker SA; Wanzel O; Berger R; Kettner SC; Coraim F
    Anesth Analg; 1998 Nov; 87(5):985-8. PubMed ID: 9806669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
    Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
    Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation.
    Korn RL; Fisher CA; Livingston ER; Stenach N; Fishman SJ; Jeevanadam V; Addonizio VP
    J Thorac Cardiovasc Surg; 1996 May; 111(5):1073-84. PubMed ID: 8622305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits.
    Ernofsson M; Thelin S; Siegbahn A
    Scand J Thorac Cardiovasc Surg; 1995; 29(4):157-65. PubMed ID: 8789468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
    Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
    Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit?
    Mahmood S; Bilal H; Zaman M; Tang A
    Interact Cardiovasc Thorac Surg; 2012 Apr; 14(4):406-14. PubMed ID: 22228288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass.
    Spanier TB; Chen JM; Oz MC; Edwards NM; Kisiel W; Stern DM; Rose EA; Schmidt AM
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):860-9. PubMed ID: 9806393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
    Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
    Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits.
    Aldea GS; O'Gara P; Shapira OM; Treanor P; Osman A; Patalis E; Arkin C; Diamond R; Babikian V; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1998 Feb; 65(2):425-33. PubMed ID: 9485240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.